Schedule 13G ownership disclosure

PTC Therapeutics Inc

Security class unavailable · CUSIP: 69366J200

Event date: 2020-04-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,819,459
Percent of class
10.8500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-20-000385
Form type
SC 13G
Filer
PTC THERAPEUTICS, INC.
CIK
CIK 1070081
Filed
May 08, 2020
Reporting period
Apr 30, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub